We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
+0.25%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$119B
AUM Growth
+$5.64B
(+5%)
Cap. Flow
+$6.41B
Cap. Flow
% of AUM
5.41%
Top 10 Holdings %
Top 10 Hldgs %
16.36%
Holding
4,406
New
331
Increased
2,055
Reduced
1,449
Closed
309
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.02B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$944M |
| 3 |
AT&T
T
|
+$753M |
| 4 |
Vanguard Extended Market ETF
VXF
|
+$553M |
| 5 |
Linde
LIN
|
+$379M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
APC
Anadarko Petroleum
APC
|
+$331M |
| 2 |
FDC
First Data Corporation
FDC
|
+$331M |
| 3 |
GWR
Genesee & Wyoming Inc.
GWR
|
+$312M |
| 4 |
Blackstone
BX
|
+$277M |
| 5 |
FirstEnergy
FE
|
+$261M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.59% |
| 2 | Technology | 10.75% |
| 3 | Financials | 9.31% |
| 4 | Consumer Discretionary | 6.45% |
| 5 | Communication Services | 5.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TCDA
3451
DELISTED
Tricida, Inc. Common Stock
TCDA
| $399K | ﹤0.01% |
12,917
+3,392
| +36% | +$114K |
|
|
TSC
3452
DELISTED
TriState Capital Holdings, Inc.
TSC
| $398K | ﹤0.01% |
18,957
+1,678
| +10% | +$34.4K |
|
3453
Alector
ALEC
$168M
| $397K | ﹤0.01% |
+27,614
| New | +$498K |
|
3454
Harte-Hanks
HHS
$16.2M
| $397K | ﹤0.01% |
130,286
-36
| -0% | -$113 |
|
3455
Ichor Holdings
ICHR
$2.62B
| $397K | ﹤0.01% |
16,434
+3,735
| +29% | +$88.4K |
|
3456
El Pollo Loco
LOCO
$501M
| $397K | ﹤0.01% |
36,177
-3,706
| -9% | -$39.2K |
|
3457
Nicolet Bankshares
NIC
$3.6B
| $397K | ﹤0.01% |
5,966
-929
| -13% | -$59.9K |
|
|
PDS
3458
Precision Drilling
PDS
$999M
| $397K | ﹤0.01% |
17,431
+6,226
| +56% | +$181K |
|
3459
Precigen
PGEN
$2.24B
| $396K | ﹤0.01% |
69,133
-2,084
| -3% | -$14.2K |
|
|
JCP
3460
DELISTED
J.C. Penney Company, Inc.
JCP
| $396K | ﹤0.01% |
445,788
-315,400
| -41% | -$265K |
|
3461
PUT
Prospect Capital
PSEC
$1.07B
| $395K | ﹤0.01% |
60,000
| – | – |
|
|
AMAG
3462
DELISTED
AMAG Pharmaceuticals
AMAG
| $395K | ﹤0.01% |
34,247
+1,798
| +6% | +$18.9K |
|
|
CMRX
3463
DELISTED
Chimerix, Inc.
CMRX
| $394K | ﹤0.01% |
+167,906
| New | +$485K |
|
3464
Parsons
PSN
$4.72B
| $392K | ﹤0.01% |
11,914
-919
| -7% | -$32.8K |
|
|
CFXA
3465
DELISTED
Colfax Corporation 5.75% Tangible Equity Units
CFXA
| $392K | ﹤0.01% |
3,000
| – | – |
|
|
EXTN
3466
DELISTED
Exterran Corporation
EXTN
| $391K | ﹤0.01% |
30,006
+6,073
| +25% | +$73.4K |
|
3467
Fortuna Silver Mines
FSM
$2.55B
| $390K | ﹤0.01% |
126,212
-8,785
| -7% | -$32.1K |
|
3468
iShares Currency Hedged MSCI Japan ETF
HEWJ
$717M
| $389K | ﹤0.01% |
12,498
-1,529
| -11% | -$45.7K |
|
3469
PUT
Automatic Data Processing
ADP
$106B
| $387K | ﹤0.01% |
2,400
| – | – |
|
|
EGIO
3470
DELISTED
Edgio, Inc. Common Stock
EGIO
| $387K | ﹤0.01% |
3,197
+197
| +7% | +$20.8K |
|
|
PKD
3471
DELISTED
Parker Drilling Company
PKD
| $384K | ﹤0.01% |
20,319
+256
| +1% | +$4.38K |
|
3472
Independent Bank Corp
IBCP
$787M
| $383K | ﹤0.01% |
17,933
-2,413
| -12% | -$50.3K |
|
3473
Manitowoc
MTW
$497M
| $383K | ﹤0.01% |
30,681
-217,822
| -88% | -$3.29M |
|
3474
iShares Russell 1000 Value ETF
IWD
$82.2B
| $382K | ﹤0.01% |
2,978
-39,957
| -93% | -$5.08M |
|
|
FSB
3475
DELISTED
Franklin Financial Network, Inc.
FSB
| $379K | ﹤0.01% |
12,555
+3,866
| +44% | +$112K |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q3 2019 Portfolio in Review
As of Q3 2019, Credit Suisse held 4,406 positions worth $119B, up 5% from $113B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Credit Suisse deployed $6.41B of net new capital in Q3 2019, opening 331 new positions and adding to 2,055 existing holdings. Its largest new stake was GW Pharmaceuticals Plc American Depositary Shares: 200,027 shares worth $23M.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 11% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Genesee & Wyoming Inc., an estimated $312M trimmed.
- Credit Suisse's largest Q3 2019 buy was GW Pharmaceuticals Plc American Depositary Shares: 200,027 shares worth $23M.
- Credit Suisse added most to Allergan plc in Q3 2019, an estimated $1.02B increase.
- Credit Suisse's biggest Q3 2019 reduction was Genesee & Wyoming Inc., cutting an estimated $312M.
- Credit Suisse fully exited Anadarko Petroleum in Q3 2019, selling an estimated $331M.
- Credit Suisse's ten largest holdings make up 16% of its $119B portfolio in Q3 2019.
- Credit Suisse opened 331 new positions and closed 309 in Q3 2019.
- Credit Suisse's portfolio value rose 5% quarter-over-quarter to $119B.
Based on Credit Suisse's 13F filing for Q3 2019, filed 12 Nov 2019.